<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0002156'>Homocystinuria</z:hpo> due to <z:chebi fb="0" ids="17755">cystathionine</z:chebi> beta-synthase deficiency is an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> disorder of methionine metabolism </plain></SENT>
<SENT sid="1" pm="."><plain>It manifests with vascular, central <z:mp ids='MP_0008912'>nervous</z:mp> system and connective tissue disturbances, and phenotypically resembles <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We analysed the clinical course of <z:hpo ids='HP_0002156'>homocystinuria</z:hpo> in Czech and Slovak patients </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: The group of homocystinuric patients consisted of 19 individuals (12 males and 7 females) aged 5-32 years (average age 18 years), who were diagnosed between 1980 and 1999 </plain></SENT>
<SENT sid="4" pm="."><plain>The overall incidence of <z:hpo ids='HP_0002156'>homocystinuria</z:hpo> in the Czech and Slovak Republics was 1:287,000 </plain></SENT>
<SENT sid="5" pm="."><plain>The proportion of <z:chebi fb="5" ids="16709">pyridoxine</z:chebi>-responsive patients was 47% </plain></SENT>
<SENT sid="6" pm="."><plain>The average follow-up period was 10 years (range 1 month to 19 years) </plain></SENT>
<SENT sid="7" pm="."><plain>The prevalence of the individual signs in the group was as follows: <z:hpo ids='HP_0001083'>lens dislocation</z:hpo>--95% of patients, progressive <z:hpo ids='HP_0000545'>myopia</z:hpo>--79%, <z:hpo ids='HP_0001519'>marfanoid habitus</z:hpo>--74%, kyfoscoliosis--68%, <z:hpo ids='HP_0000939'>osteoporosis</z:hpo>--63%, <z:hpo ids='HP_0001263'>psychomotor retardation</z:hpo>--58%, other neurologic symptomatology--58% and tromboembolism--21% </plain></SENT>
<SENT sid="8" pm="."><plain>The average delay between the first sign of the disease and the time when the diagnosis was made was 4 years (range 1 to 14 years) </plain></SENT>
<SENT sid="9" pm="."><plain>At the time of diagnosis the average levels of metabolites in plasma were as follows: total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> 348 mumol/l (range 211-536), free <z:chebi fb="0" ids="17485">homocystine</z:chebi> 70 mumol/l (range 0-203) and methionine 359 mumol/l (range 75-937) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Both the clinical course of <z:hpo ids='HP_0002156'>homocystinuria</z:hpo> due to the <z:chebi fb="0" ids="17755">cystathionine</z:chebi> beta-synthase deficiency and its incidence in the Czech and Slovak Republics are similar to those in other populations </plain></SENT>
<SENT sid="11" pm="."><plain>Since <z:hpo ids='HP_0002156'>homocystinuria</z:hpo> is a treatable disease, it should be included in the differential diagnosis of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e>, tromboembolism and severe <z:hpo ids='HP_0001263'>psychomotor retardation</z:hpo> </plain></SENT>
</text></document>